MHRA seizes fake medicine worth more than £2m
The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.
Novartis and Pfizer sign clinical development agreement
Swiss pharmaceutical company Novartis has partnered with Pfizer, its American rival, in efforts to advance the treatment of non-alcoholic steatohepatitis.
Allergan and tribe ask for stay pending SCOTUS appeal
Allergan and the Saint Regis Mohawk Tribe have urged the US Court of Appeals for the Federal Circuit to stay its ruling against them pending an appeal to the US Supreme Court.
J&J reveals plans to appeal cancer drug court ruling
Johnson & Johnson has revealed its intention to appeal against a district court’s invalidation of a patent covering its prostate cancer drug Zytiga (abiraterone acetate).
FDA improves generic approval rate under Trump: report
The US Food and Drug Administration’s generic drug approval rate has increased at a “rapid rate” since January 2017, despite the number of branded drug patent expirations declining during this period.
Interpol seizes 500 tonnes of illicit pharmaceuticals
More than 500 tonnes of illicit pharmaceuticals have been seized worldwide as part of a global operation led by Interpol, as announced on Tuesday.
Nelson Mullins adds life sciences litigator in NYC
Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel.
USITC to review Fujifilm breast imaging case
The US International Trade Commission yesterday announced that it will review in-part the final initial determination of an investigation into Fujifilm involving X-ray breast imaging.
Duane Morris names IP lawyer as pharma litigation chair
Duane Morris has appointed Patrick Gallagher as chair of the firm’s pharmaceuticals and biopharmaceuticals litigation and regulatory practice group.
EU General Court dismisses Bayer’s Aspirin trademark appeal
Trademarks covering Bayer’s branded Aspirin were at the centre of an appeal dismissed by the EU General Court yesterday.
